Yelin Lapidot Holdings Management Ltd. Arvinas, Inc. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $574 Billion
- Q4 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 46,873 shares of ARVN stock, worth $846,057. This represents 0.16% of its overall portfolio holdings.
Number of Shares
46,873
Previous 49,503
5.31%
Holding current value
$846,057
Previous $1.22 Billion
26.3%
% of portfolio
0.16%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
227Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$126 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$121 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$113 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$69.6 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$50.2 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $960M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...